Therefore, we performed a comprehensive cognitive, neuropsychological, and psychopathological assessment after 5.7 ± 2.2 years from surgery in a cohort of CHD children operated on cardiopulmonary bypass (CPB) to assess the role of GFAP in predicting long term neurodevelopmental outcome. The gene discussed is GFAP; the disease is coronary artery disorder.